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Summary
The bacterial pathogen Listeria monocytogenes rep-
licates within the cytosol of mammalian cells. Mecha-
nisms by which the bacterium exploits the host
cytosolic environment for essential nutrients are
poorly defined. L. monocytogenes is a lipoate aux-
otroph and must scavenge this critical cofactor, using
lipoate ligases to facilitate attachment of the lipoyl
moiety to metabolic enzyme complexes. Although the
L. monocytogenes genome encodes two putative
lipoate ligases, LplA1 and LplA2, intracellular replica-
tion and virulence require only LplA1. Here we show
that LplA1 enables utilization of host-derived lipoyl
peptides by L. monocytogenes. LplA1 is dispensable
for growth in the presence of free lipoate, but neces-
sary for growth on low concentrations of mammalian
lipoyl peptides. Furthermore, we demonstrate that the
intracellular growth defect of the DlplA1 mutant is
rescued by addition of exogenous lipoic acid to host
cells, suggesting that L. monocytogenes dependence
on LplA1 is dictated by limiting concentrations of
available host lipoyl substrates. Thus, the ability of
L. monocytogenes and other intracellular pathogens
to efficiently use host lipoyl peptides as a source of
lipoate may be a requisite adaptation for life within the
mammalian cell.
Introduction
Nutrient scavenging is critical for replication and persis-
tence of intracellular bacterial pathogens. The facultative
Gram-positive bacterium Listeria monocytogenes estab-
lishes a replicative niche within the host cytosol, where it
is protected from humoral immunity. Cytosolic growth of
L. monocytogenes is rapid, approximating the doubling
time of the bacterium in rich broth culture (Marquis et al.,
1993). Upon entry into the host cell, L. monocytogenes
escapes from the phagosome by secreting a cholesterol-
dependent cytolysin, Listeriolysin O (LLO) (Portnoy et al.,
2002). LLO-deficient bacteria remain within the vacuole,
do not proliferate and are rapidly cleared by the
host immune response (Bouwer et al., 1992). Thus,
L. monocytogenes must access the cytosol in order to
replicate within an infected host. Although the host cytosol
contains many nutrients that support its own growth, non-
adapted bacterial species like Bacillus subtilis or Yersinia
enterocolitica placed in the cytosolic environment repli-
cate poorly (Portnoy et al., 1992; Goetz et al., 2001).
These observations suggest that L. monocytogenes has
adaptations for survival and nutrient acquisition that
facilitate rapid cytosolic growth; however, relatively little
is known about how L. monocytogenes exploits the
biochemical environment of the host cell.
The requirements for in vitro replication of
L. monocytogenes are well defined. For optimal growth in
defined medium, the bacterium requires nine essential
amino acids, vitamins (biotin, lipoic acid, riboflavin and
thiamine), as well as a carbon source such as glucose
(Phan-Thanh and Gormon, 1997; Tsai and Hodgson,
2003). The mechanisms of nutrient acquisition during
L. monocytogenes intracellular growth have not been
extensively studied. At this time, several processes have
been empirically demonstrated to directly promote intrac-
ellular replication of L. monocytogenes via synthesis or
transport of essential nutrients. These include hexose
phosphate transport, aromatic amino acid biosynthesis
and activation of pyruvate dehydrogenase (PDH) by the
lipoate ligase-like protein, LplA1. The hexose phosphate
transporter, hpt, contributes to optimal intracellular growth
by L. monocytogenes through uptake of glucose
phosphates, which are abundant in the host cytosol
(Chico-Calero et al., 2002). Hpt mutant bacteria are
approximately 10-fold less virulent than wild-type bacteria
in a mouse model of infection. Genes involved in aromatic
amino acid biosynthesis (aroA, aroB and aroE) are also
important during intracellular growth; deletion of any one
of these genes results in a 104-fold decrease in virulence
(Stritzker et al., 2004). Lastly, the lipoate ligase-like
protein, LplA1, is necessary for intracellular, but not
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extracellular growth (O’Riordan et al., 2003). The LD50 of
LplA1-deficient L. monocytogenes is 250-fold greater
than the wild-type parental strain in C57BL/6 mice dem-
onstrating the importance of LplA1 for virulence.
The function of lipoate ligases has been extensively
characterized in the model organism Escherichia coli
(Morris et al., 1994; 1995; Fujiwara et al., 2005). Lipoate,
a thiol-containing cofactor, is essential for the oxidative
decarboxylation reactions of aerobic metabolism, and
also acts as an antioxidant (Jordan and Cronan, 1997;
Bast and Haenen, 2003). Lipoate ligases catalyse forma-
tion of an amide linkage between lipoate and a conserved
lysine residue within target apoenzymes that include com-
ponents of the PDH, a-ketoglutarate dehydrogenase
(KGDH) and glycine H cleavage complexes (Perham,
2000; Zhao et al., 2003). E. coli can synthesize lipoyl
groups de novo, but also scavenges extracellular lipoate
by a pathway dependent on the lipoate protein ligase LplA
(Morris et al., 1995). L. monocytogenes is a lipoate
auxotroph and does not encode the genes necessary
for lipoate biosynthesis (Welshimer, 1963; Glaser et al.,
2001). However, the L. monocytogenes genome encodes
two proteins, termed LplA1 and LplA2, that share 54%
and 49% similarity, respectively, with E. coli LplA (Glaser
et al., 2001). The presence of two LplA-like enzymes in
L. monocytogenes suggests the possibility that the bacte-
rium uses two distinct external sources of lipoic acid.
Deletion of the lplA1 gene impairs bacterial replication
and lipoylation of L. monocytogenes PDH within host
cells, but not in rich medium (O’Riordan et al., 2003). As
LplA1 and LplA2 are not redundant during intracellular
replication, we hypothesized that LplA1 might be required
for utilization of a host-derived form of lipoate. Here we
show that LplA1 enables L. monocytogenes to use small
host-derived lipoyl peptides, revealing an adaptive
mechanism to exploit the host cytosol for essential
nutrients.
Results
LplA1 and LplA2 both contribute to PDH lipoylation
during extracellular growth
Deletion of lplA1 impairs growth and lipoylation of bacte-
rial protein in the intracellular environment, but not in a
rich complex medium, brain–heart infusion (BHI) broth,
suggesting that L. monocytogenes encodes a second
functional lipoate ligase (O’Riordan et al., 2003). LplA1
shares significant amino acid identity and similarity with
LplA2 (lmo0764) and E. coli LplA (Fig. S1) (Glaser et al.,
2001). To determine whether lplA2 contributes to lipoyla-
tion during extracellular growth, we constructed strains
containing an in-frame deletion of lplA2, or a disruption of
both lplA1 and lplA2, and examined modification of bac-
terial proteins after growth in BHI (Fig. 1A). The DlplA1
and DlplA2 mutant strains exhibited lipoyl modification of a
75 kDa protein, previously identified as the E2 subunit of
L. monocytogenes PDH (LmPDH), indicating that either
enzyme could function during growth in rich medium
(O’Riordan et al., 2003). In contrast, the double mutant
(lplA1::Tn917DlplA2) showed no detectable lipoylation.
Both the DlplA1 and DlplA2 mutant strains grew similarly
Fig. 1. L. monocytogenes has two functional lipoate ligase activities.
A. Equivalent numbers of stationary phase wild type (WT), DlplA1, DlplA2 and lplA1::Tn917DlplA2 L. monocytogenes, based on OD600, were
pelleted and protein harvested using the FastProtein™ Blue Matrix (MP Biomedicals). Bacterial lysates were analysed by SDS-PAGE, followed
by immunoblot with an anti-lipoic acid antibody. The band slightly below 75 kDa has previously been identified by Mass-Spectrometry as
lipoyl-E2-PDH (O’Riordan et al., 2003). Relative intensities of the bands to wild type were calculated using ImageJ. Loading of equivalent
bacterial lysates was confirmed by stripping the blot and reprobing with an anti-E2 antibody (Stein and Firshein, 2000). Bacteria were grown in
both the rich medium BHI and IMM, a medium that is limiting for lipoate; lplA1::Tn917DlplA2 was only studied in BHI as it exhibited impaired
growth in IMM.
B. Wild-type L. monocytogenes and the DlplA1 and DlplA2 mutant strains were grown in IMM containing different concentrations of lipoic acid.
The OD600 was measured after bacteria had reached stationary phase (30 h) and plotted against lipoic acid concentration. The OD600 was
measured in a Bioscreen Growth Curve Analyzer.
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to the parental wild-type L. monocytogenes strain in BHI,
but the lplA1::Tn917DlplA2 strain exhibited slower growth
(data not shown). Modification of LmPDH was also mea-
sured in bacteria grown in improved minimal medium
(IMM) containing free lipoic acid (Fig. 1A). LmPDH lipoy-
lation was decreased in the single mutants compared with
the wild-type strain. However, the single mutants grew as
well as wild-type L. monocytogenes in IMM, demonstrat-
ing functional redundancy of LplA1 and LplA2 in medium
containing free lipoic acid (Fig. 1B). While we could
observe limited growth of the double mutant in BHI, this
strain did not grow in IMM, thus the lplA1::Tn917DlplA2
strain was not used for further analysis in this study
(data not shown). These data demonstrate that at least
one of these enzymes, LplA1 or LplA2, is necessary for
lipoyl modification in L. monocytogenes.
LplA1, but not LplA2, contributes to bacterial virulence
in a mouse model of infection
As both LplA1 and LplA2 enabled lipoate ligase activity in
the extracellular environment, we used an animal model
of infection to define their respective contributions to
in vivo growth and virulence. C57BL/6 mice were in-
fected intraperitoneally (i.p.) with wild-type and mutant
L. monocytogenes, and colony-forming units (cfu) from
spleen and liver were enumerated at 72 h (Fig. 2A). The
bacterial burden in mice infected with wild-type or DlplA2
bacteria was several orders of magnitude higher than
mice infected with the DlplA1 mutant strain (Fig. 2A). We
also assessed the ability of DlplA1 and DlplA2 mutants to
compete against wild-type L. monocytogenes by per-
forming a competitive index (CI) analysis. Mice were
co-infected with wild-type and mutant L. monocytogenes
and cfu were enumerated at 72 h (Fig. 2B). The CI was
calculated by dividing the number of wild-type cfu (anti-
biotic sensitive) by the mutant cfu (antibiotic resistant).
While the CI of the DlplA1 strain was approximately 32
and 603 in liver and spleen respectively, the CI of the
DlplA2 strain was close to 1 for both liver and spleen.
These data indicate that LplA2 does not contribute to
bacterial fitness or virulence in vivo. In contrast, success-
ful replication of L. monocytogenes in a mouse model of
infection required LplA1, even in the presence of LplA2.
LplA1 is required for intracellular growth using
host-derived lipoate
We hypothesized that attenuation of virulence and loss of
lipoylation in the DlplA1 mutant strain was due to inability
of the remaining ligase-like protein, LplA2, to use lipoate
from the host cytosol. To ensure that intracellular growth
was dependent upon host-derived lipoate, we starved
wild-type, DlplA1 and DlplA2 strains in IMM without lipoic
acid prior to intracellular infection. LmPDH was exten-
sively lipoylated when the bacteria were grown in the
presence of free lipoic acid, but loss of PDH modification
was observed in the absence of exogenous lipoate
Fig. 2. Bacterial virulence in vivo requires
LplA1, but not LplA2.
A. 2 ¥ 105 total cfu of exponentially growing
cultures of wild-type and mutant
L. monocytogenes were injected i.p. into ten
5- to 7-week-old male C57BL/6 mice. After
72 h, spleens and livers were harvested,
homogenized and plated onto LB.
B. Exponentially growing cultures of wild-type
and mutant L. monocytogenes were mixed at
a 1:10 (WT : DlplA1) or 1:1 ratio (WT : DlplA2)
and 2 ¥ 105 total cfu injected i.p. into six 5- to
7-week-old male C57BL/6 mice. After 72 h,
spleens and livers were harvested,
homogenized and plated onto LB with or
without 1 mg ml-1 erm. The competitive index
was calculated by dividing the number of
wild-type strain cfu (ermS) by the number of
mutant cfu (ermR). The horizontal line
represents the median value. Statistically
significant differences between two groups
were determined by the Student’s t-test at
P < 0.05, as indicated by the symbol ‘*’.
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(Fig. 3A). To test the respective contributions of LplA1 and
LplA2 towards intracellular growth, bacteria grown with or
without lipoic acid were used to infect J774 macrophages.
Wild-type and LplA2-deficient L. monocytogenes exhi-
bited similar intracellular growth whether or not the bac-
teria were lipoate starved (Fig. 3B). However, lipoate-
starved DlplA1 mutant bacteria no longer replicated within
host cells. These results show that LplA2 is dispensable
for intracellular growth, but demonstrate an absolute
requirement for LplA1 in utilization of host-derived lipoate
for proliferation in the macrophage cytosol.
Attenuated intracellular growth by the DlplA1 mutant
could be explained by lack of lplA2 expression or an
absence of substrate utilized by LplA2-dependent mecha-
nisms inside the host cell. To examine whether attenuated
intracellular growth of the DlplA1 mutant strain was due to
lack of intracelluar lplA2 expression, we measured levels
of lplA1 and lplA2 transcript by quantitative reverse tran-
scriptase polymerase chain reaction (qRT-PCR) in wild-
type L. monocytogenes isolated from J774 macrophages
at 6 h post infection. lplA2 transcripts were present in
intracellular bacteria, albeit at lower levels than lplA1
(Fig. 3C). As there is no detectable free lipoate found in
the cytosol, we next investigated if lack of intracellular free
lipoate was the limiting factor for growth of the DlplA1
strain in the cytosol (Akiba et al., 1998; Podda et al.,
1994). Prior to infection, we incubated J774 macrophages
with 50 mM dihydrolipoic acid (DHLA) and assessed
the effect of supplementation on intracellular growth
(Fig. 3D). DHLA supplementation did not further enhance
the intracellular growth of wild-type L. monocytogenes but
did rescue growth of the DlplA1 mutant. Taken together,
these results suggest LplA2 is competent to enable intra-
cellular bacterial growth only if free lipoate is added
exogenously. As LplA2 does not normally contribute to
intracellular growth, we propose that the requirement for
LplA1 during cytosolic replication of L. monocytogenes
results from the absence of lipoyl substrates used by an
LplA2-dependent pathway.
Host-derived lipoyl peptides support LplA1-dependent
growth of L. monocytogenes
Lipoyl moieties in mammalian cells are primarily found
attached to host proteins rather than as free lipoic acid
(Akiba et al., 1998; Perham, 2000). We therefore hypoth-
esized that LplA1, but not LplA2, would permit utilization
of lipoyl peptides found in the host cytosol. The predomi-
Fig. 3. LplA1, but not LplA2, is essential for intracellular growth.
A. A culture of wild-type L. monocytogenes grown in IMM with or without lipoic acid was grown at 37°C to stationary phase, and protein was
harvested as in Fig. 1. Bacterial lysates were analysed by immunoblot using an anti-lipoic acid antibody. The 75 kDa band (black arrowhead)
corresponds to the L. monocytogenes E2-PDH. Porcine PDH was used as a positive control for the anti-lipoic acid antibody. Loading of
equivalent bacterial lysates was confirmed by reprobing the blot with polyclonal anti-Listeria antibody.
B. Wild-type, DlplA1 and DlplA2 bacterial strains were grown in IMM in the presence (dashed lines) or absence (solid lines) of lipoic acid
overnight at 37°C, and used to infect J774 cell cultures. Intracellular growth was quantified by enumerating cfu.
C. Wild-type bacteria were grown in BHI overnight at 37°C and used to infect J774 cells. At 6 h post infection, WT infected J774 cells were
lysed and bacteria isolated. Quantitative RT-PCR was performed in triplicate on isolated bacterial RNA to determine template quantities of
rpoA, lplA1 and lplA2. Template quantities were normalized against rpoA levels. To control for genomic DNA contamination, a portion of each
RNA sample was removed from the reaction prior addition of reverse transcriptase (labelled ‘no RT’) and analysed by QRT-PCR.
D. Starved bacterial strains were used to infect J774 cells with (dashed lines) or without (solid lines) 50 mM DHLA, then cells were lysed and
cfu were enumerated. For all growth curves, the mean  SD was calculated for each time point (n = 3).
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nant lipoyl proteins in J774 macrophages are the E2
subunit of PDH (PDH-E2) and the E2 subunit of
a-ketoglutarate dehydrogenase (KGDH-E2), as mea-
sured by immunoblot analysis of whole cell lysates using
anti-E2/E3 and anti-LA antibodies (data not shown).
However, full-length lipoylated PDH-E2 and KGDH-E2 are
localized to the mitochondrial matrix and would likely
be unavailable to cytosolic bacteria (Margineantu et al.,
2002). To determine if lipoylated proteins were present in
the cytosol of J774 macrophages, cytosolic and mitochon-
drial fractions were analysed by SDS-PAGE and immuno-
blot using an anti-lipoic acid antibody (Fig. 4A). We
consistently observed a similar profile of low-molecular-
weight lipoylated proteins in the cytosol of uninfected or
infected J774 cells. The lipoylated proteins in the cytosolic
fraction were unlikely to be the result of mitochondrial
rupture during preparation as the abundant mitochondrial
E2 PDH and KGDH full-length proteins were not observed
in the cytosolic fraction, even though it was concentrated
100-fold. These data suggest that L. monocytogenes has
access to lipoyl groups in the host cytosol in the form of
lipoylated polypeptides.
As lipoyl groups in mammalian cells are protein bound,
we tested the ability of modified host proteins, such as
PDH-E2 and KGDH-E2, to act as a sole source of lipoyl
groups for L. monocytogenes in defined minimal medium
(IMM). After lipoate pre-starvation, lipoylated porcine PDH
did not support L. monocytogenes growth (Fig. 4B).
However, it was possible that L. monocytogenes could not
transport the large PDH holoenzyme complex. To deter-
mine if LplA1 could enable bacterial utilization of smaller
lipoylated peptides, we digested porcine PDH with trypsin,
a treatment predicted to release a lipoyl peptide of 17
amino acids in length. Trypsin-digested PDH was not able
to supplement growth of L. monocytogenes (Fig. 4B).
Thus, the lipoyl peptides generated by trypsin digestion
either were not transported into the bacteria, or were not
suitable substrates for LplA1-dependent ligase activity. In
contrast, proteinase K (ProK)-digested porcine PDH or
KGDH, which would be predicted to contain lipoylated
Fig. 4. LplA1 enables utilization of degraded host-derived PDH for bacterial growth.
A. J774 cell lysate was separated into cytosolic and mitochondrial fractions as described in Experimental procedures. Mitochondrial fractions
and concentrated cytosolic fractions (100¥) were analysed by immunoblot using a rabbit polyclonal anti-lipoic acid antibody. The 70 kDa band
corresponds to mammalian E2-PDH, while the 55 kDa band corresponds to mammalian E2-KGDH.
B. Wild-type (WT) L. monocytogenes was grown in IMM without lipoic acid supplemented with proteinase K (ProK)-digested, trypsin
(Tryp)-digested or undigested porcine PDH. Growth was measured by OD600 and the mean value  SD was calculated for each time point
(n = 3).
C. Wild-type and DlplA1 L. monocytogenes were grown in IMM containing undigested or ProK-digested porcine PDH or KGDH at 5 mg l-1.
After 35 h of growth in the Bioscreen Growth Curve Analyzer, bacterial cultures had reached stationary phase, and the OD600 values were
plotted for each condition. BSA at 5 mg l-1 was also digested with ProK as a negative control. Mean values  SD were calculated for each
time point (n = 3).
D. Wild-type, DlplA1 and DlplA1 complemented with a plasmid expressing LplA1 were grown in IMM containing the lipoate sources indicated;
ProK-digested BSA at 5 mg l-1 was used as a negative control. Free lipoic acid (206 Da) (5 mg l-1) and ProK-digested porcine PDH (5 mg l-1)
were dialysed against a 100 Da or a 500 Da MWCO membrane, and the retentate was used to supplement IMM. After 19.5 h of growth in
conical tubes, the bacterial cultures had reached stationary phase; OD600 values for this time point were plotted for each condition. Growth
was not determined (ND) for BSA and LA filtration experiments for DlplA1 and DlplA1 complemented with a plasmid expressing LplA1.
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tripeptides (~520 Da), supported growth of wild type but
not DlplA1 (Fig. 4B and C). The increase in bacterial
growth upon ProK digestion of PDH or KGDH was not due
to the presence of contaminating free lipoate in ProK, or
an increase in non-lipoylated peptides, as ProK-digested
BSA did not support replication.
We next considered the possibility that LplA1-
dependent growth using ProK-digested PDH was due to
the release of free lipoamide from PDH. To detect free
lipoamide that may have been generated by ProK diges-
tion, we dialysed ProK-digested PDH using a membrane
with a 500 Da molecular weight cut-off (MWCO), and
supplemented minimal medium with the retentate
(> 500 Da) as a potential lipoate source. As lipoic acid
(206 Da) and lipoamide (205 Da) are both smaller than
500 Da, retentate from a control filtration of free lipoic acid
using a membrane with a 500 Da MWCO failed to stimu-
late bacterial growth. Similarly, filtered ProK-digested
PDH-supplemented growth of the wild-type bacteria to the
same extent (Fig. 4D). However, the DlplA1 mutant was
unable to grow in the presence of the 500 Da retentate,
unless complemented by a plasmid containing the lplA1
gene. As a control for the accuracy of the MWCO of the
dialysis membranes, we confirmed that retentate of a free
lipoic acid solution after dialysis against a 100 Da MWCO
was able to supplement growth of wild-type bacteria.
These results demonstrate that LplA1 permits L. monocy-
togenes usage of degraded host lipoyl proteins as a sole
source of lipoic acid.
LplA1 is required for utilization of the synthetic lipoyl
tripeptide DKLA
The predicted lipoyl tripeptide released from porcine PDH
and KGDH after ProK digestion shares amino acid identity
with human, murine and rat lipoyl domains (Fig. 5A). To
establish that LplA1-mediated growth of L. monocytoge-
nes was dependent upon lipoyl peptide and not other
non-modified peptides, we used synthetic lipoyl DKA
(DKL.A), the smallest lipoyl peptide predicted from ProK
digestion of porcine PDH (Fig. 5A, Fig. S2A and B). At
5 mg l-1, DKL.A supported growth of wild type but not
DlplA1, demonstrating the specific contribution of LplA1 in
utilizing lipoylated peptides for proliferation (Fig. 5B). To
Fig. 5. LplA1 is required for optimal growth on small lipoyl peptides.
A. The amino acid sequences of the dihydrolipoyl transacylase lipoyl domain from Homo sapiens (Accession No. AAA64512),
dihydrolipoamide S-acetyltransferase lipoyl domain of Bos taurus (Accession No. XP_588501), dihydrolipoamide branched chain transacylase
E2 lipoyl domain of Mus musculus (Accession No. NP_034152), dihydrolipoamide S-acetyltransferase lipoyl domain of Rattus norvegicus
(Accession No. AAI07441) and the dihydrolipoamide acetyltransferase lipoyl domain of Sus scrofa (Accession No. NP_999159) aligned.
B. Wild-type (WT) L. monocytogenes and the DlplA1 mutant strain were grown in IMM containing 5 mg l-1 DKL.A, or 5 mg l-1 non-lipoylated
DKA. The OD600 was measured over time in a Bioscreen Growth Curve Analyzer and plotted as a function of time.
C. Wild-type L. monocytogenes and the DlplA1 mutant strain were grown as in (B), but in IMM containing different concentrations of DKL.A.
The OD600 was measured after bacteria had reached stationary phase (25 h) and plotted against lipoyl peptide concentration.
D. Bacterial growth curves were performed as in (B), but 0.5 mg l-1 tripeptide (lipoylated or non-lipoylated) was added with or without prior
aminopeptidase M digestion as indicated.
E. Bacterial growth curves were performed as described in (B), but in IMM containing the concentrations of lipoamide indicated. After 30 h of
growth, bacteria had reached stationary phase, and OD600 values were plotted against lipoamide concentration. The mean value  SD was
calculated for each time point (n = 3) in (B–E).
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test whether replication required the lipoyl moiety, we also
supplemented IMM with non-lipoylated tripeptide (DKA),
which did not support L. monocytogenes growth in the
absence of any lipoyl substrate even at very high
concentrations. To determine the optimal concentration of
lipoyl peptide for LplA1-mediated multiplication, we per-
formed a dose–response curve by adding DKL.A to
lipoate-starved bacterial cultures (Fig. 5C). Lower con-
centrations of lipoyl tripeptide only supported replication
of wild-type bacteria, while high concentrations supported
growth of both the wild-type and DlplA1 mutant strains.
These results imply that LplA2 can also use lipoyl pep-
tides for growth, but only at very high concentrations. Our
data suggest that the concentration of available lipoyl
peptide in the host cytosol is low, resulting in dependence
on LplA1 for intracellular replication of L. monocytogenes.
To determine if LplA1 could support growth with smaller
lipoyl peptides than lipoylated tripeptides, we digested
lipoylated DKL.A with the protease aminopeptidase M
(Fig. S2C). Unlike the preferential growth of wild-type bac-
teria mediated by undigested lipoyl DKL.A, peptide diges-
tion products allowed growth of both the wild-type and
DlplA1 strains, suggesting that lipoyl dipeptide or lipoyl
lysine does not dictate LplA1-dependent bacterial growth
(Fig. 5D). Thus, LplA1 allows bacterial proliferation in low
concentrations of lipoyl peptides, and the length of the
modified peptide may determine preferential usage by
LplA1 over LplA2. We also investigated if the free amide
derivation of lipoate, lipoamide, supported LplA1-
dependent replication of L. monocytogenes. Although
there was a slight difference in growth by the DlplA1
mutant strain as compared with wild-type bacteria at sub-
optimal lipoamide concentrations, both wild type and
DlplA1 replicated in lipoamide-containing medium, dem-
onstrating that lipoamide did not define the host-specific
requirement for LplA1 (Fig. 5E). Overall, these data
indicate that LplA1 facilitates growth of L. monocytogenes
on lipoyl peptides, the predominant intracellular form
of lipoate.
L. monocytogenes LplA1 exhibits lipoate ligase activity
Our results suggest a model in which intracellular growth
of L. monocytogenes using small host-derived lipoyl pep-
tides is dependent upon LplA1. If LplA1 is able to directly
use lipoyl substrates, we predicted that the lplA1 gene
would complement an E. coli strain deficient in lipoate
utilization, TM131, which cannot grow in minimal medium
without a functional lipoate ligase (Morris et al., 1995). As
E. coli LplA has been shown biochemically to have lipoate
ligase enzymatic activity, this complementation strategy
has been used to demonstrate functionality of lipoate
ligases from organisms as diverse as the protozoan para-
site Plasmodium falciparum and Arabidopsis thaliana
(Wada et al., 2001; Allary et al., 2007). We grew TM131 in
metabolic bypass medium (+succinate +acetate) to allow
transformation with an IPTG-inducible plasmid expressing
E. coli lplA, L. monocytogenes lplA1 or the vector alone.
All transformants grew on bypass medium (Fig. 6A), but
only E. coli lplA and L. monocytogenes lplA1 comple-
mented growth of TM131 when acetate and succinate
were removed (Fig. 6B and C). However, TM131 express-
ing lplA1 grew to a lesser extent, indicating that the
L. monocytogenes lipoate ligase only partially compen-
sated for the loss of endogenous E. coli lipoate ligase
activity. We were not able to confirm expression of LplA2
in the TM131 strain transformed with an IPTG-inducible
lplA2 plasmid although the plasmid could direct LplA2
expression in a wild-type E. coli strain, thus it is still
unknown whether LplA2 can act directly as a functional
lipoate ligase (Fig. S3A and data not shown). As
expected, expression of both L. monocytogenes lplA1
and E. coli lplA resulted in lipoylation of the E2 subunit of
PDH (Fig. S3B). Thus, complementation of the E. coli
TM131 mutant by L. monocytogenes lplA1 suggests that
LplA1 can act enzymatically as a lipoate ligase.
To explore if there might be a structural basis for
the difference in lipoate ligase activity between L.
monocytogenes LplA1 and LplA2, we modelled the struc-
ture of L. monocytogenes LplA1 and LplA2 using previ-
ously published crystal structures of the E. coli and
Streptococcus pneumoniae LplA proteins (Fujiwara et al.,
2005). Every residue in the lipoyl AMP-binding pocket
predicted to interact with substrate or residues identified
as being important for binding of the target apo-
domain was conserved between the E. coli and L.
monocytogenes enzymes (Fig. S1) (Kim et al., 2005).
However, the electrostatic surface topology was notably
different between the three enzymes, with an overall elec-
trostatic potential for LplA1 of -13, while LplA2 and E. coli
LplA exhibit electrostatic potentials of -5 and -8 respec-
tively (Fig. 7). Moreover, LplA1 exhibited several regions
of clustered negatively charged residues, which might
modulate interaction of LplA1 with other proteins or
cofactors. These predicted structural differences are con-
sistent with our observations that L. monocytogenes
LplA1 and LplA2 have overlapping but distinct functions.
Discussion
Intracellular pathogens such as L. monocytogenes have
evolved mechanisms to take advantage of the biochemi-
cal environment of the host cell; the study of these mecha-
nisms can reveal critical parameters of the host–pathogen
interaction. The essential nutrient lipoic acid is scarce in
the host cell in its free form, but our data demonstrate
lipoylated polypeptides are present in low abundance in
the cytosol where L. monocytogenes replicates. Although
764 K. M. Keeney, J. A. Stuckey and M. X. D. O’Riordan
© 2007 The Authors
Journal compilation © 2007 Blackwell Publishing Ltd, Molecular Microbiology, 66, 758–770
L. monocytogenes has two lipoate ligases, LplA1 and
LplA2, only LplA1 was required for intracellular growth
and virulence. LplA2 was sufficient for lipoylation of target
proteins and growth in rich broth medium, which contains
free lipoate, but was insufficient during intracellular infec-
tion by L. monocytogenes. We showed that LplA1 was
necessary for L. monocytogenes growth in low concentra-
tions of lipoyl peptide, yet was dispensable for growth in
medium containing free lipoic acid or growth in host cells
supplemented with free lipoic acid. These data suggest
that optimal replication in the intracellular environment by
L. monocytogenes requires LplA1-dependent utilization of
host-derived lipoyl peptides.
Local concentrations of host lipoyl peptide vary widely
depending primarily on the concentration of mitochondria
in that tissue (Baker et al., 1998). As LplA1 and LplA2
both support growth with high concentrations of lipoyl
peptide, tissues that contain high amounts of lipoylated
proteins, such as the liver, may be able to support more
extensive bacterial growth (Baker et al., 1998). The DlplA1
strain was substantially less able to compete with the
wild-type strain in spleen when compared with liver; this
tissue preference could be due to a higher concentration
of lipoyl peptide in the liver supporting more robust repli-
cation in the absence of LplA1. However, the spleen also
contains more immune effector cells that use oxidative
stress as a host defence, which might also contribute to
decreased fitness of the DlplA1 mutant. Lipoic acid is a
potent antioxidant that may help bacteria survive oxidative
stress; by allowing efficient utilization of host lipoyl pep-
tides, LplA1 may promote L. monocytogenes survival in
the spleen (Bryk et al., 2002). Scavenging lipoate is a
known growth requirement for several pathogens, such as
the auxotrophic bacteria Enterococcus faecalis and
L. monocytogenes (Reed et al., 1951). Even pathogenic
organisms that synthesize lipoate, such as the protozoan
parasites Toxoplasma gondii and Plasmodium falciparum,
still scavenge lipoate from the host environment, as the
parasite biosynthetic pathways supply only the apicoplast
and not the mitochondrion (Wrenger and Muller, 2004;
Crawford et al., 2006; Allary et al., 2007). Thus, the use of
host-derived lipoate may be more widespread among
intracellular pathogens than previously appreciated. The
ability to utilize nutrients from diverse host pools is a
Fig. 6. Complementation of an E. coli strain deficient in lipoate utilization by L. monocytogenes (L.m.) LplA1. E. coli TM131 (lplA –lipA –)
transformed with an empty IPTG-inducible vector, or the same vector expressing E. coli LplA or L. monocytogenes LplA1. TM131 is deficient in
lipoate biosynthesis as well as endogenous LplA; growth requires either exogenous expression of a lipoate ligase, or supplementation with
acetate and succinate. Clones expressing either empty vector, E. coli LplA or L. monocytogenes LplA1 were streaked on M9 minimal medium
plates containing IPTG and free lipoic acid. Acetate and succinate were included in (A), but not (B) and (C). The boxes illustrated in (B) are
magnified in (C) for viewing of single colonies. Some putative E. coli revertants were observed (large white colony observed in the insert of the
LplA1-expressing E. coli strain).
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common theme in pathogenesis, as other essential com-
pounds like iron are scavenged in multiple forms to enable
optimal replication (Skaar et al., 2004).
Our structural models of LplA1 and LplA2 suggest that
these enzymes share with E. coli LplA the basic catalytic
mechanism by which free lipoate is activated and trans-
ferred to target apoproteins (Morris et al., 1994; 1995).
The amino acid residues involved in the binding of the
lipoyl group and the target domain appear to be con-
served in both E. coli LplA and the L. monocytogenes
lipoate ligases (Fig. S1). However, the enzymatic mecha-
nism by which LplA1 can enable use of low concentra-
tions of lipoyl peptide is still unknown. Utilization of lipoyl
peptide by LplA1 would mandate a distinct enzymatic
mechanism from ligation of free lipoic acid as synthesis of
the activated lipoyl AMP intermediate requires the car-
boxyl group of lipoate, lacking in lipoyl peptides. The sim-
plest model would predict that, in addition to its LplA-like
activity, LplA1 could bind directly to lipoyl peptides and
transfer the lipoyl group from the peptide to the target
domain, by a mechanism more analogous to LipB-
mediated transfer of octanoyl groups from an acyl-carrier
protein to the target apoprotein (Zhao et al., 2003; Ma
et al., 2006). Although LplA contains no cysteines, which
would be required for the lysine/cysteine catalytic dyad
characterized in LipB, a cysteine could conceivably be
provided by a hybrid interface with an interacting protein
(Ma et al., 2006). In this model, LplA1 would bind to lipoyl
peptides with higher affinity than LplA2, allowing LplA1 to
function efficiently at lower substrate concentrations. As
an alternative model, the clustered negatively charged
regions on the surface of LplA1 could represent sites of
interaction with a critical cofactor. For example, LplA1
may have intrinsic lipoamidase activity or associate with a
protein with lipoamidase activity, thus liberating lipoamide
from lipoyl peptides and increasing the local concentration
of free lipoamide. Such lipoamidase activity would have to
be strictly regulated, as it would oppose ligase function
(Jiang and Cronan, 2005). Future structure–function
studies will elucidate which model more accurately
Fig. 7. Structural Modelling of L. monocytogenes (L.m.) LplA1 and LplA2. Electrostatic surface potentials for the crystallographic structure
E. coli (E.c.) LplA (PDB ID 1X2H) and the modelled structures of LplA1 and LplA2 were calculated using APBS (Baker et al., 2001) and
mapped onto their respective solvent accessible surfaces using Pymol (DeLano, 2002). Negative potentials (-10 kT e-1) are shown in red,
positive potentials (10 kT e-1) in blue. The views for individual molecules are separated by a 90° rotation about the x-axis. The protein
structures are shown at the same magnification and orientation for each view.
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Strains used in this study are described in Table 1. For intra-
cellular growth curves, all L. monocytogenes strains were
grown to mid-log (OD600 0.2–0.6) in IMM at 37°C unless
otherwise specified. IMM was prepared as previously
described (Phan-Thanh and Gormon, 1997), using the con-
centrations listed in Table 1 of the referenced paper. Specifi-
cally, lipoic acid was used to supplement IMM at 5 mg l-1
except when otherwise specified in the figure legends, or
substituted where indicated with various concentrations of
lipoamide (0–5 mg l-1), DKL.A (0–25 mg l-1), digested lipoyl
PDH (5 mg l-1) or digested lipoyl KGDH (5 mg l-1). For growth
curves in IMM, single colonies from freshly streaked BHI
plates were inoculated into IMM without lipoic acid (IMM–L) for
10–14 h at 37°C shaking to OD600 0.2–0.4, back-diluted to an
OD600 of 0.02 in IMM and cultured at 37°C shaking. Bacterial
growth was determined by measuring changes in OD600 over
time. All IMM growth curves, except the experiment shown in
Fig. 4D, were performed in a Bioscreen Growth Curve Ana-
lyzer (Growth Curves, USA).
Allelic exchange
Astrain containing an in-frame deletion of lplA2 was generated
using homologous recombination. The deletion allele was
obtained by amplifying 3′ and 5′ genomic sequences flanking
lplA2 that were then fused by splice overlap extension-PCR
(Horton et al., 1990). The 0.8 kb fragments were amplified
from the 10403S bacterial genome with Platinum Pfx poly-
merase (Invitrogen) using primer sequences described in
Table S1. The PCR product was subcloned into the allelic
exchange vector, pKSV7 (Smith and Youngman, 1992). Allelic
exchange was performed as previously described and con-
firmed by sequencing (O’Riordan et al., 2003). The in-frame
deletion resulted in removal of amino acids 30–300 out of 330
amino acids (strain MOR129). The transposon insertion that
disrupted lplA1 in DP-L2214 (O’Riordan et al., 2003) was
transduced as previously described (Hodgson, 2000;
O’Riordan et al., 2003) into MOR129 to generate a strain
deficient in both putative lipoyl ligases (lplA1Tn::917DlplA2;
MOR125). For complementation studies, pAM401 and
pAM401lplA1 were transformed individually into DP-L4263
and 10403S as previously described (O’Riordan et al., 2003).
Mouse infections
Monotypic and CI infections were performed as previously
described with the following modifications (Auerbuch et al.,
2001). Exponential phase bacterial cultures were diluted in
Ca2+- and Mg2+-free Dulbecco’s phosphate-buffered saline,
and 2 ¥ 105 bacteria in 200 ml were injected i.p. into 4- to
6-week-old C57BL/6 J mice (Jackson Laboratories, Bar
Harbor, ME). At 72 h post infection, the animals were sacri-
ficed, and livers and spleens homogenized in 0.1% NP-40,
serially diluted, and plated onto Luria–Bertani (LB) agar. For
the CI infections, the homogenization buffer also contained
0.1 mg ml-1 erythromycin (erm), and the lysate was plated on
LB agar with or without 1 mg ml-1 erm. The CI was calculated
by dividing the number of wild-type cfu (erm sensitive) by the
number of mutant cfu (erm resistant).
Quantitative real-time polymerase chain reaction
After infection of J774 macrophages at a multiplicity of infec-
tion (moi) of 1:1 for 6 h, host cells were lysed with 50 mM Tris,
pH 8, 150 mM NaCl and 0.05% NP-40 for 10 min on ice. After
vortexing and pelleting the host nuclei at 3000 g for 30 s, the
remaining supernatant was used to isolate bacterial RNA with
the Pro-Blue Fast RNA kit (MP Biomedicals) followed by
DNase digestion on Qiagen RNeasy minicolumns. cDNA was
generated from 2.5 mg of RNA using random primers and
M-MLV reverse transcriptase (Invitrogen). Primers for lplA1,
lplA2 and rpoA (Table S1) were used to amplify cDNA, which
was quantified by SYBR Green fluorescence (Stratagene
Mx3000p).
Lipoyl substrates
Lipoamide (T5875), PDH (P-7032) and KGDH (K1502) were
purchased from Sigma-Aldrich. Prior to using commercial
PDH and KGDH, the enzymes were precipitated and washed
with Bio-Rad ReadyPrep 2-D Cleanup Kit. Trypsin digestion
was performed at 30°C for 4 h in 0.02% Tween-20 and
200 mM ammonium bicarbonate (pH 8.9). The proteins were
Table 1. Strains used.
Strains Genotype/description Reference
10403S L. monocytogenes serotype 1/2a, parental strain used as wild type Freitag et al. (1993)
MOR125 10403S lplA1::Tn917DlplA2 This study
MOR129 10403S DlplA2 This study
DP-L3903 L. monocytogenes 10403S::Tn917, unknown site of insertion, wild-type phenotype Auerbuch et al. (2001)
DP-L4263 10403S DlplA1 O’Riordan et al. (2003)
MOR142 10403S DlplA1 (DP-L4263) containing the Tn917 insertion transduced from DP-L3903 This study
JK1 E. coli rpsL Morris et al. (1995)
TM131 E. coli rpsL lipA182::Tn1000dKn lplA148::Tn10dTc Morris et al. (1995)
MOR226 E. coli rpsL lipA182::Tn1000dKn lplA148::Tn10dTc + ptac85 This study
MOR229 E. coli rpsL lipA182::Tn1000dKn lplA148::Tn10dTc + ptac85-ECLplA This study
MOR227 E. coli rpsL lipA182::Tn1000dKn lplA148::Tn10dTc + ptac85-LMLplA1 This study
MOR228 E. coli rpsL lipA182::Tn1000dKn lplA148::Tn10dTc + ptac85-LMLplA2 This study
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digested with a ratio of 1 mg of protein to 8 mg of proteomics
grade trypsin in a total volume of 500 ml; the reaction was
stopped with 0.0003% trifluoroacetic acid. ProK digestion
was performed at a ratio of 5 mg of protein to 20 mg of
enzyme (Sigma P-4850) in 20 mM Tris-HCl, 1 mM CaCl2 at
pH 7.4 at 25°C for 4 h and heat inactivated for 10 min at
90°C. Enzymatic digestion was confirmed by SDS-PAGE and
immunoblotting analysis for lipoylated peptides. For dialysis
experiments, ProK-digested samples were loaded in 100 or
500 Da Spectra/Por Micro DispoDialyzer membranes and
dialysed against 20 mM Tris-HCl, 1 mM CaCl2 at pH 7.4.
Synthetic lipoyl tripeptide DKL.A was synthesized by Anaspec
using a previously published protocol (Fig. S2A and B)
(Konishi et al., 1996). Digestion of DKL.A with immobilized
aminopeptidase M was performed at a ratio of 0.5 U enzyme
to 250 mg of peptide for 18 h at 37°C (Pierce; #20238); diges-
tion was confirmed by LC-MS on a nanoAcuity/Qtof premier
instrument. The non-digested and digested samples were
injected on a C18 column and analysed in positive ion mode
(Fig. S2C). Non-lipoylated DKA was synthesized and LC-MS
was performed by the Protein Structure Facility of the
University of Michigan Medical School.
Subcellular fractionation
Mitochondria were isolated by lysis of 1 ¥ 107 macrophages
in 10 mM HEPES pH 7.9, 1.5 mM MgCl2, 10 mM KCl, 0.5 mM
DTT and 0.2 mM PMSF, incubation on ice for 10 min and
vortexing for 1 min. After lysis, salts were added to a final
concentration of 30 mM HEPES (pH 7.9), 140 mM KCl and
3 mM MgCl2. After removing nuclei by centrifuging at 3000 g
for 30 s and washing three times, mitochondria were spun at
80 000 g for 4 h at 4°C. The remaining supernatant was
retained and concentrated in a 3 kDa Ultracel YM-3 Centricon
Centrifugal Filter Device (Amicon).
Protein analysis
Bacteria were prepared and analysed by immunoblot with
an anti-lipoic acid antibody (Calbiochem) as previously
described (O’Riordan et al., 2003) except washed exponen-
tial phase cultures (OD600 0.5) were used after growth in
IMM–L or BHI at 37°C. Protein lysate was prepared with
FastProtein Blue Lysing Matrix (MP Biomedicals) by process-
ing in a FastPrep machine for 40 s at a setting of 6.0 in Lysing
Matrix B. For cytosolic and mitochondrial peptide analysis by
immunoblot, 0.75 M Tris-HCl was used in the resolving gel,
running buffer and loading buffer.
Bacterial infections
J774 macrophages were infected as previously described
(O’Riordan et al., 2003) except washed exponential phase
cultures grown at 37°C in IMM–L pre-starved bacteria were
used at a moi of 3, resulting in ~10% macrophage infection.
In DHLA (Sigma-Aldrich T-8260) supplementation experi-
ments, 50 mM DHLA was added to the J774 macrophage
growth medium prior to infection and maintained throughout
the infection. Addition of high concentrations of non-reduced
lipoic acid resulted in precipitation, as well as non-specific
host cell effects. Data points represent the mean with stan-
dard deviation.
E. coli complementation
TM131 (rpsL lipA182::Tn1000dKn lplA148::Tn10dTc) and its
parental wild-type strain JK1 (rpsL) were transformed with
E. coli lplA, L. monocytogenes lplA1 or lplA2 in the IPTG-
inducible ptac85 plasmid and plated onto LB agar containing
0.4% glucose, 5 mM sodium acetate, 5 mM sodium succinate
and 100 mg ml-1 ampicillin. Primers used to amplify the
lipoate ligase genes with Pfx platinum polymerase are listed
in Table S1. TM131-transformed strains were also grown
in the presence of 50 mg ml-1 kanamycin and 125 mg ml-1
tetracycline. Transformants were restreaked onto M9 minimal
medium plates containing 0.4% glucose, 1 mM IPTG, thia-
mine (10 mg ml-1), 2 mM MgSO4, 0.1 mM CaCl2 and the
appropriate antibiotics with or without 5 mM sodium acetate
and 5 mM sodium succinate as indicated. Lysates for
Western blotting were grown in LB containing 0.4% glucose,
5 mM sodium acetate, 5 mM sodium succinate, 1 mM IPTG
and the appropriate antibiotics.
Structural modelling of LplA1 and LplA2
Because of its high homology with LplA1 (65.8%) and LplA2
(66.6%), the structure of LplA from S. pneumoniae (PDB ID:
1VQZ; Joint Center for Structural Genomics) was used as the
foundation for modelling the LplA1 and LplA2 structures. To
model the bound forms of LplA1 and LplA2, the N- and
C-terminal domains of 1VQZ were first aligned onto the
respective domains of the lipoate-bound form of E. coli LplA
(PDB ID: 1X2H) using the graphics program O, then the amino
acid sequence of 1VQZ was mutated into that of LplA1 (Jones
et al., 1991; Fujiwara et al., 2005). Amino acid insertions and
deletions were fit using the lego-loop option in O. The resulting
LplA1 model was then placed into a box of waters containing
a minimum of two shells of water, minimized and put through
simulated annealing using torsion angle dynamics in Crystal-
lography & NMR System (CNS; Brunger et al., 1998). The
lipoate structure from 1X2H was attached to the NZ atom of a
modelled lysine residue using O. CNS parameter and topology
files for the lipoate-lysine residue were created via the HIC-Up
server (http://xray.bmc.uu.se/cgi-bin/gerard/hicup_server.pl).
The tripeptide (DKL.A) was then created via CNS and modelled
into the refined LplA1 model using O. Simulated annealing
was then performed on the DKL.A-bound LplA1 model. To
create the LplA2 model, the amino acid sequence of LplA2
was overlaid onto the bound form of LplA1. The resulting
DKL.A-bound LplA2 model was placed into a box of waters and
put through simulated annealing.
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